Wealthfront’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
$1.37M Buy
15,323
+3,805
+33% +$340K 0.01% 195
2018
Q2
$915K Sell
11,518
-1,865
-14% -$148K 0.01% 269
2018
Q1
$1.19M Sell
13,383
-7,582
-36% -$676K 0.01% 221
2017
Q4
$2.19M Sell
20,965
-16,141
-43% -$1.68M 0.02% 113
2017
Q3
$5.41M Buy
37,106
+4,147
+13% +$605K 0.07% 50
2017
Q2
$4.28M Sell
32,959
-157
-0.5% -$20.4K 0.06% 53
2017
Q1
$4.12M Buy
33,116
+6,581
+25% +$819K 0.07% 51
2016
Q4
$3.07M Buy
26,535
+8,608
+48% +$996K 0.07% 52
2016
Q3
$1.87M Buy
17,927
+3,721
+26% +$389K 0.04% 69
2016
Q2
$1.4M Buy
14,206
+2,346
+20% +$231K 0.04% 78
2016
Q1
$1.19M Sell
11,860
-4,052
-25% -$406K 0.04% 82
2015
Q4
$1.91M Buy
15,912
+304
+2% +$36.4K 0.07% 54
2015
Q3
$1.69M Buy
15,608
+5,390
+53% +$583K 0.07% 58
2015
Q2
$1.18M Buy
10,218
+823
+9% +$95.3K 0.05% 48
2015
Q1
$1.08M Buy
9,395
+587
+7% +$67.7K 0.05% 39
2014
Q4
$985K Buy
8,808
+2,362
+37% +$264K 0.06% 38
2014
Q3
$611K Buy
6,446
+781
+14% +$74K 0.04% 50
2014
Q2
$511K Buy
5,665
+4,897
+638% +$442K 0.04% 40
2014
Q1
$56K Buy
+768
New +$56K 0.01% 240